Live Breaking News & Updates on Padcev Europe

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Seattle Genetics (NASDAQ: SGEN)
Good day and welcome to Seagen first-quarter 2021 financial results conference call. [Operator instructions] After today s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I would now like to turn the conference over to Peggy Pinkston, senior vice president of investor relations.
Please go ahead.
Senior Vice President of Investor Relations
Thank you, operator, and good afternoon, everyone. I d like to welcome all of you to Seagen s first-quarter 2021 financial results conference call. This afternoon, we issued a press release with our results. The press release and supporting slides are available on our website in the investor section, events and presentations page. ....

United Kingdom , United States , Great Britain , Cory Kasimov , Andy Hsieh , Peggy Pinkston , Sheldon Chuan Barclays , Stephen Willey , Tisotumab Vedotin , Gena Wang , Salveen Richter Goldman Sachs , Connor Meehan Morgan Stanley , Kennen Mackay , Andrew Berens , Padcev Europe , Salveen Richter , Geoff Meacham , Jay Olson , America Merrill Lynch , Greg Harrison , Clay Siegall , Zhiqiang Shu , Ladiratuzumab Vedotin , Michael Schmidt Guggenheim , Reni Benjamin , Roger Dansey ,